Alternative N-Terminal Domains of PSD-95 and SAP97 Govern Activity-Dependent Regulation of Synaptic AMPA Receptor Function  by Schlüter, Oliver M. et al.
Neuron 51, 99–111, July 6, 2006 ª2006 Elsevier Inc. DOI 10.1016/j.neuron.2006.05.016Alternative N-Terminal Domains of PSD-95
and SAP97 Govern Activity-Dependent
Regulation of Synaptic AMPA Receptor FunctionOliver M. Schlu¨ter,1,2 Weifeng Xu,1,2
and Robert C. Malenka1,*
1Nancy Pritzker Laboratory
Department of Psychiatry and Behavioral Sciences
Stanford University School of Medicine
Palo Alto, California 94304
Summary
PSD-95 and SAP97 are scaffolding proteins that have
been implicated in regulating AMPA receptor incor-
poration and function at synapses. Gain- and loss-
of-function approaches, however, have generated
conflicting results. To minimize adaptations during
development and potential dominant-negative effects
of overexpression, we have combined silencing of
endogenous PSD-95 in mature neurons with heterol-
ogous expression of specific SAP97 or PSD-95 iso-
forms. We find that both PSD-95 and SAP97 contain
alternative N termini expressing either double cyste-
ines that normally are palmitoylated (a-isoforms) or
an L27 domain (b-isoforms). Whereas a-isoforms of
PSD-95 and SAP97 influence AMPA receptor-medi-
ated synaptic strength independent of activity, the
effects of b-isoforms are regulated by activity in a
CaMKII-dependent manner. Importantly, the synaptic
effects of the b-isoforms are masked by the endoge-
nous a-isoform of PSD-95. These results demonstrate
that the different N termini of the predominant endog-
enous forms of PSD-95 (a-isoform) and SAP97 (b-iso-
form) govern their role in regulating synaptic function.
Introduction
Changes in strength at glutamatergic synapses are
considered to be fundamentally important for informa-
tion processing and storage in the brain. One important
mechanism for the regulation of synaptic strength is the
synaptic incorporation and retrieval of AMPA receptors
(AMPARs), the principal receptors for fast excitatory
neurotransmission in the mammalian central nervous
system (Bredt and Nicoll, 2003; Malinow and Malenka,
2002; Song and Huganir, 2002). Recent evidence sug-
gests a key role for postsynaptic scaffolding proteins
from the disc-large (DLG) subfamily of membrane-asso-
ciated guanylate kinases (MAGUKs) in regulating synap-
tic AMPAR trafficking (Beique and Andrade, 2003; Ehr-
lich and Malinow, 2004; El-Husseini et al., 2000; Funke
et al., 2005; Kim and Sheng, 2004; Montgomery et al.,
2004; Nakagawa et al., 2004; Rumbaugh et al., 2003;
Scannevin and Huganir, 2000; Schnell et al., 2002; Stein
et al., 2003). Family members include PSD-95/SAP90,
PSD-93/Chapsyn110, SAP97, and SAP102, with the
most extensively studied family members being PSD-
95 and SAP97. While overexpression of PSD-95 in
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tures consistently enhances AMPAR-mediated excitatory
postsynaptic currents (AMPAR EPSCs), but not NMDA
receptor-mediated EPSCs (NMDAR EPSCs) (Beique
and Andrade, 2003; Ehrlich and Malinow, 2004; Naka-
gawa et al., 2004; Schnell et al., 2002), the synaptic con-
sequences of overexpressing SAP97 have been incon-
sistent. An enhancement of the frequency of AMPAR
miniature EPSCs in dissociated neuronal cultures and
the amplitude of AMPAR EPSCs in hippocampal slice
cultures has been reported by some investigators (Na-
kagawa et al., 2004; Rumbaugh et al., 2003) while others
observed no effect in this latter preparation (Ehrlich and
Malinow, 2004; Schnell et al., 2002).
Genetic deletions or loss-of-function mutants of DLG-
MAGUK family members, on the other hand, consis-
tently have been found to have minimal effects on basal
synaptic transmission. Specifically, genetic knock out of
PSD-95 at synapses was reported to have no effect on
basal synaptic transmission in the CA1 region of the hip-
pocampus, although long-term depression was absent
(Migaud et al., 1998). Similarly, knock out of PSD-93,
the only family member normally present in cerebellar
Purkinje cells, had no detectable effect on synaptic
structure or function in the cerebellum (McGee et al.,
2001). Although loss-of-function mutants of SAP97 and
Dlg, its Drosophila ortholog, are lethal due to major de-
fects in cell-cell contact formation during embryogene-
sis (Caruana and Bernstein, 2001; Lahey et al., 1994;
Woods and Bryant, 1991), neurons cultured from the
SAP97 mutant embryos develop normally and form syn-
apses with normal levels of AMPARs and no detectable
abnormalities (Klocker et al., 2002). These findings raise
the possibility that DLG-MAGUK family members share
redundant functions in neurons and loss of one can be
partially compensated by other family members. Alter-
natively, other adaptive processes during synaptogene-
sis and synapse maturation might compensate for the
loss of the normal function of DLG-MAGUKs in basal
synaptic transmission.
The detailed structures of the various DLG-MAGUKs
provide clues as to whether family members are redun-
dant or have functionally distinct roles. All share a com-
mon modular structure of five protein-protein interaction
domains; specifically, three N-terminal PDZ domains are
followed by an SH3 and an enzymatically inactive GK
domain (Funke et al., 2005; Kim and Sheng, 2004; Mont-
gomery et al., 2004; Scannevin and Huganir, 2000). How-
ever, SAP97 and PSD-95, the most extensively studied
family members, have two important differences. First,
they interact with AMPAR subunits via distinct mecha-
nisms: SAP97 appears to directly bind to the AMPAR
subunit GluR1 (Cai et al., 2002; Leonard et al., 1998) while
PSD-95 requires stargazin to interact with AMPARs
(Fukata et al., 2005). Second, their N-terminal do-
mains can differ (Cho et al., 1992; Muller et al., 1995).
The predominant isoform of PSD-95 has an N-terminal
domain, which is palmitoylated and also capable of
multimerizing PSD-95 with itself and other MAGUKs
with a palmitoylated N terminus, such as PSD-93 (Hsueh
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nus of PSD-95 appears to be particularly important for
its synaptic targeting (Craven et al., 1999). In contrast,
SAP97 contains a longer N-terminal L27 domain, capa-
ble of heteromultimerization and homomultimerization
with itself and other L27 domain-containing proteins,
such as CASK (Lee et al., 2002). Although synaptic tar-
geting of SAP97 is thought to be dependent on the pres-
ence of the alternatively spliced exon I3, which is local-
ized in the SH3-GK linker (Rumbaugh et al., 2003), the
multimerization of SAP97 via its L27 domain has recently
been suggested to also be important for mediating its
synaptic effects (Nakagawa et al., 2004). Interestingly,
a small proportion of PSD-95 in the brain contains
an N-terminal L27 domain (Chetkovich et al., 2002), but
the functions of this isoform have not been examined.
To further examine and clarify the roles of PSD-95 and
SAP97 in the regulation of basal excitatory synaptic
transmission and provide explanations for some of these
apparently conflicting results, we have taken a different
approach to study the molecular basis of synaptic func-
tion. Specifically, we have used a cell-restricted, molec-
ular replacement strategy, in which expression of endog-
enous PSD-95 is acutely reduced via RNAi and replaced
by specific isoforms of the DLG-MAGUK family. Our
results suggest that the specific roles of PSD-95 and
SAP97 in synaptic function are governed by differences
in their N-terminal domains, which impart activity depen-
dence or independence on their function.
Results
SAP97, PSD-95, and PSD-93 Have Similar
Alternative N-Terminal Domains
Both PSD-95 and PSD-93 are expressed in brain with
one of two alternative N-terminal domains (Chetkovich
et al., 2002; Parker et al., 2004) containing either an N-
terminal cysteine doublet that is palmitoylated (Topinka
and Bredt, 1998) or an N-terminal L27 domain, similar
to SAP97. To determine whether such alternative N ter-
mini are a feature common to all DLG-MAGUK family
members, we first searched the National Center for Bio-
technology Information (NCBI) expressed sequence tag
(EST) database. This resulted in the identification of one
mouse EST clone (BY131151) that originates from the
SAP97 gene and codes for N-terminal double cysteines
identical to the a-isoform of PSD-95. We next analyzed
the rat gene structures of all four DLG-MAGUKs, PSD-
95, PSD-93, SAP97, and SAP102, in more detail to reveal
common elements of the gene structures (Figure 1A).
For their N-terminal regions, SAP97 and PSD-95 share
a common gene structure that contains three b-exons
that code for an L27 domain and one a-exon that codes
for the cysteine doublet (Figure 1A). Either the b-exons
or the a-exon are spliced into the common exon 2.
PSD-93 shares a common gene structure with PSD-95
and SAP97 but also has an additional a-exon spliced
into exon 2 and three unique alternative N termini coding
exons, which are spliced into exon 3 (Figure 1A) (Parker
et al., 2004). On the other hand, compared to other DLG-
MAGUK family members, the N terminus coding region
of SAP102 is unique in that it lacks any of the a- or b-
exons that are spliced into exon 2 (Figure 1A).To determine whether SAP97 is indeed transcribed
in rat brain with two alternative 50 sequences, we per-
formed RT-PCR analysis. This confirmed the presence
of different species of SAP97 mRNA, one coding for a
potentially palmitoylated cysteine pair (SAP97a) and
the other coding for an L27 domain (SAP97b) (Figure 1B).
Thus both PSD-95 and SAP97, the two most extensively
studied DLG-MAGUKs, are present in brain in two iso-
forms; the a-isoforms contain an N-terminal cysteine
doublet that is normally palmitoylated, and the b-iso-
forms contain an L27 domain. To date, virtually all studies
on these proteins have focused only on either the proto-
typic PSD-95a or the prototypic SAP97b. We were there-
fore interested in how these domains might underlie
differences in the synaptic function of these molecules.
PSD-95 is the Principal MAGUK in the Hippocampus
Although PSD-95, SAP97, and PSD-93 are known to be
expressed in the hippocampus (Sans et al., 2000), be-
fore examining potential functional differences between
the a- and b-isoforms of PSD-95 and SAP97, it was im-
portant to have some knowledge about their relative
abundance. We first expressed GFP-tagged PSD-95a,
PSD-93a, and SAP97b in HEK293 cells, and using an
anti-GFP antibody, their expression levels were ad-
justed to provide reference points for the quantification
of different DLG-MAGUKs in crude synaptosomal frac-
tions of juvenile hippocampus (Figure 1C, middle panel).
An antibody that recognizes both a- and b-isoforms of
DLG-MAGUKs detected prominent bands at 95 kDa
and 120 kDa, the former representing PSD-95 and the
latter, according to its size, SAP97b (Figure 1C, left
panel). To determine whether DLG-MAGUK family mem-
bers other than PSD-95 might contribute to the 95 kDa
band, we examined extracts from PSD-95 knockout
mice and found no DLG-MAGUK close to this molecular
weight (Figure 1C, right panel). Thus, PSD-95 and
SAP97b appear to be the only DLG-MAGUKs with either
a palmitoylated N terminus or an L27 domain detectable
in the hippocampus by Western blotting. Although this
analysis did not allow independent measurement of
the a- and b-isoforms of PSD-95, previous work has
found that the majority of brain PSD-95 is the a-isoform,
with only w10% of brain PSD-95 being the b-isoform
with an N-terminal L27 domain (Chetkovich et al.,
2002). Assuming that the single band at 95 kDa repre-
sents PSD-95a, this indicates that PSD-95a was far
more abundant than SAP97b, the levels of which were
w16% of PSD-95a levels in the hippocampus.
RNAi-Mediated Acute Reduction in PSD-95
Decreases Synaptic Strength
There are striking inconsistencies between the synaptic
effects of overexpressing PSD-95, which greatly en-
hances basal synaptic transmission (Beique and An-
drade, 2003; Ehrlich and Malinow, 2004; Nakagawa
et al., 2004; Schnell et al., 2002), versus genetically delet-
ing it, which has minimal effects on synaptic strength
(Migaud et al., 1998). To examine the synaptic function
of the different isoforms of PSD-95 and SAP97, we
therefore reasoned it would be advantageous to express
them in cells in which endogenous PSD-95 was acutely
reduced. This approach minimizes compensatory adap-
tations due to the lack of PSD-95 during synaptogenesis
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101Figure 1. Analysis of Endogenous DLG-MAGUKs and Lentivirus Preparation
(A) (Top panel) Comparison of genomic structures of the N termini of DLG-MAGUKs. Gray boxes represent constitutive exons; open boxes, al-
ternatively spliced exons. (Bottom panels) sequence alignment of predicted N-terminal amino acid sequences of a- and b- isoforms of PSD-95
and SAP97 and indicated intron-exon boundaries. Gray areas highlights identical amino acid residues; light gray highlights similar residues.
(B) SAP97awas transcribed in different brain regions as detected by RT-PCR (CX, cerebral cortex; CB, cerebellum; HP, hippocampus; MB, mid-
brain; TH, thalamus; [-], negative control). One common downstream primer P2 and two upstream primers Pa and Pb, specific to SAP97a and
SAP97b, respectively, were used in the PCR reaction. GAPDH specific primers were used as a control for total RNA level.
(C) Quantitative western blots probed with anti-a/b-DLG antibody show that PSD-95a is the predominant brain DLG-MAGUK. (Left panel)
Samples from three rat hippocampus P2 fractions. (Middle panel) Homogenates from HEK293 cells expressing GFP-tagged forms of indicated
proteins. (Right panel) Hippocampus homogenates from wild-type and PSD-95 knockout mice.
(D) Diagram of lentivirus vectors for shRNA, molecular replacement, and overexpression (LTR, long terminal repeat; c, packaging signal; Flap,
flap element from HIV-1; pH1, H1 promoter; pUb, ubiquitin promoter; WRE, woodchuck hepatitis virus posttranscriptional regulatory element).
Below are shown the products of the various cDNAs (the [*] above PSD95::eGFP indicates silent mutations).
(E) Western blot of cortical neuron cultures infected with the indicated lentiviruses shows effective knockdown of endogenous PSD-95 via sh95
and successful replacement with PSD-95::GFP (blotted with anti-a/b-DLG antibody).
(F) (Left panel) Image of the recording setup from hippocampal slice culture at low magnification. The double-barreled stimulation electrode was
placedw150 mm away from the CA1 cell body layer in stratum radiatum (scale bar, 100 mm). (Right panel) Overlay of DIC image and GFP fluo-
rescence at high magnification showing the GFP-infected cell and the uninfected neighboring cell, from which simultaneous recordings were
made (scale bar, 15 mm).and synapse maturation and, in addition, opens the
possibility of analyzing the function of heterologously
expressed constructs without the necessity of a domi-
nant effect as required by a standard overexpression
approach. To accomplish this task, we constructed a
dual promoter lentiviral vector in which the human H1
promoter drove expression of a shRNA to PSD-95, while
an ubiquitin promoter simultaneously drove expression
of GFP or a GFP-fusion protein (Figure 1D). The shRNA
to PSD-95 (sh95) was highly effective in silencing hetero-logous PSD-95 expression in HEK293 cells (data not
shown) as well as endogenous PSD-95 when introduced
into dissociated cortical cultures using lentivirus-medi-
ated gene transfer (Figure 1E). Indeed, Western blot
analysis showed that endogenous PSD-95 expression
could be silenced efficiently when examined over a
week after infection (Figure 1E). Furthermore, immuno-
cytochemical examination of endogenous PSD-95 in
cells expressing sh95 revealed no detectable puncta
(data not shown).
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102Figure 2. Acute Knockdown of PSD-95 Depresses AMPAR EPSCs and Its Replacement by PSD-95a Enhances AMPAR EPSCs
(A) Sample traces simultaneously recorded from sh95-expressing and control cells (scale bars, 50 ms, 10 pA).
(B) Amplitude of AMPAR EPSCs of neurons expressing sh95 for various durations are plotted against those of simultaneously recorded unin-
fected neighboring neurons. (Gray symbols represent single pairs of recordings; black symbols show mean 6 SEM; p values were calculated
with a paired Student’s t test comparing absolute values of paired recordings).
(C) Summary (mean6 SEM) of effects of sh95 on AMPAR- and NMDAR EPSCs calculated as the averaged ratios obtained from pairs of infected
and uninfected neighboring neurons (numbers of pairs analyzed are indicated in the bar; n.s. indicates p > 0.05 using an ANOVA Tukey HSD
t test).
(D) Summary of the normalized ratios of AMPAR EPSCs to NMDAR EPSCs in sh95-expressing and uninfected neighboring cells (***p < 0.001,
paired t test).
(E) Sample traces showing EPSCs in response to paired-pulse stimulation (scale bars, 20 pA, 50 ms).
(F) Paired-pulse ratios of AMPAR EPSCs for pairs of recordings (black symbol shows mean 6 SEM, which was less than diameter of symbol).
(G) Amplitudes of AMPAR EPSCs of neurons expressing PSD-95a alone (left panel) or sh95 and PSD-95a (right panel) versus control neurons.
Sample traces are shown above. Scale bars, 20 pA, 50ms.
(H) Summary of effects on AMPAR EPSCs (left panel) and NMDAR EPSCs (right panel) of expressing sh95 alone, PSD-95a alone, and both
together (n.s. p > 0.05, ***p < 0.001).To allow for expression of recombinant PSD-95 in the
same cells expressing sh95, silent mutations were intro-
duced into the sh95-targeted region of the GFP-tagged
PSD-95 cDNA (Figure 1D). In cortical cultures infected
with this lentivirus, endogenous PSD-95 is efficiently
silenced, whereas the recombinant GFP-tagged protein
is expressed at levels comparable to cultures infected
with a lentivirus lacking the shRNA expression cassette
(Figure 1E). These results demonstrate that endogenous
PSD-95 in neurons can be efficiently knocked down and
replaced by a recombinant protein using this bicistronic
lentiviral expression system.
To investigate the acute effect of knocking down en-
dogenous PSD-95 on AMPAR EPSCs, we injected con-
centrated sh95-expressing lentivirus into the CA1 cellbody layer of hippocampal slice cultures the day after
plating. GFP expression in individual cells could be de-
tected as early as two days after infection. This allowed
us to make simultaneous whole-cell voltage-clamp re-
cordings from an infected and neighboring uninfected
cell while stimulating the same Schaffer collateral axons
(Figure 1F). Consistent with a previous study (Nakagawa
et al., 2004), AMPAR EPSCs were reduced on average
by 35%–45% in cells expressing sh95 (n = 181 pairs)
(Figures 2A–2C). The magnitude of the reduction in
AMPAR EPSCs was examined at three different time
points from 3 to 8 days after infection and was not signif-
icantly different (Figures 2B and 2C), demonstrating that
the synaptic effect of silencing PSD-95 is constant over
this time period. In contrast to the clear effects on
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affected by acute reduction of PSD-95 (n = 149 pairs)
(Figure 2C). Consistent with these results, the ratio of
AMPAR EPSCs to NMDAR EPSCs was significantly
reduced in cells expressing sh95 (n = 145 pairs) (Fig-
ure 2D). The lack of effect of sh95 on NMDAR EPSCs
is important not only because it supports a specific
role for PSD-95 in AMPAR-mediated synaptic transmis-
sion, but also because it rules out the possibility that the
lentivirus-mediated expression of this shRNA had some
nonspecific deleterious effect on cell or synapse health.
As an additional control, an ineffective shRNA to PSD-95
was expressed and had no detectable effect on either
AMPAR or NMDAR EPSCs (n = 15 pairs, p > 0.05).
Overexpression of PSD-95 during synaptogenesis
modulates presynaptic maturation (El-Husseini et al.,
2000), and the paired-pulse ratio (PPR) of AMPAR-medi-
ated synaptic responses, a measure of presynaptic
function, was altered in PSD-95 knockout mice (Migaud
et al., 1998). It was therefore of interest to examine the
PPR in cells expressing sh95. In contrast to these previ-
ous results, however, acute knockdown of PSD-95 had
no detectable effect on the PPR (n = 16 pairs) (Figures
2E and 2F). Thus there are at least two differences in
the synaptic consequences of acutely reducing PSD-
95 with shRNA versus genetically deleting it: the acute
knockdown of PSD-95 depresses AMPAR EPSCs but
has no detectable effect on presynaptic function, while
knocking out PSD-95 leaves basal synaptic transmis-
sion intact but leads to changes in presynaptic function
(Migaud et al., 1998).
We next examined the synaptic effects of overexpres-
sion of PSD-95a using lentiviral-mediated gene transfer
with and without simultaneous expression of sh95. Un-
der these two conditions, expression of PSD-95a en-
hanced AMPAR EPSCs to approximately the same de-
gree (n = 21 and 38 pairs, respectively) (Figures 2G and
2H). The magnitude of this enhancement (2- to 2.5-fold)
was less than previously reported using gene gun-medi-
ated gene transfer (3.5- to 8-fold; Nakagawa et al., 2004;
Schnell et al., 2002), presumably because the levels of
recombinant PSD-95a are lower with lentivirus, which
causes random integration of few copies of the cDNA
into genomic DNA (Lois et al., 2002). The ‘‘rescue’’ of
the sh95-mediated synaptic depression by PSD-95a
suggests that this isoform alone is responsible for medi-
ating the increase in synaptic strength, as the sh95 si-
lences both a- and b-isoforms of PSD-95. We also exam-
ined NMDAR EPSCs in cells expressing recombinant
PSD-95a, and consistent with previous results (Beique
and Andrade, 2003; Ehrlich and Malinow, 2004; Naka-
gawa et al., 2004; Schnell et al., 2002), they were not
significantly affected (Figure 2H).
SAP97b Rescues the Decrease of AMPAR EPSCs
Due to PSD-95 Knockdown
The prototypic SAP97 is the b-isoform (SAP97b), which
contains a L27 domain in its N-terminal region (Lee
et al., 2002; Muller et al., 1995). In previous work using
hippocampal slice cultures, overexpression of SAP97b
produced either no effect on AMPAR EPSCs (Ehrlich
and Malinow, 2004; Schnell et al., 2002) or an increase,
which was much less than that observed with overex-
pression of PSD-95a (Nakagawa et al., 2004). Consistentwith these findings, overexpression of SAP97b contain-
ing the I3 insert, which is required for synaptic targeting
in dissociated neuronal cultures (Rumbaugh et al.,
2003), had no significant effect on either AMPAR EPSCs
(n = 19 pairs) or NMDAR EPSCs (n = 15 pairs) (Figures 3A
and 3C). We also examined two additional SAP97b iso-
forms containing different inserts in the SH3-GK linker
region (I2 or I2I5I4 containing) (McLaughlin et al., 2002;
Wu et al., 2000), and these also had no detectable effect
on AMPAR EPSCs (data not shown).
Surprisingly, however, when SAP97b was expressed
with sh95 such that endogenous PSD-95 levels were se-
verely reduced, it had a very clear effect; AMPAR EPSCs
were no longer depressed by the sh95 (n = 35 pairs) (Fig-
ures 3B and 3C). NMDAR EPSCs, on the other hand,
were unaffected (n = 30 pairs) (Figures 3B and 3C).
Thus there was a dramatic difference in the effects of
recombinant SAP97b on AMPAR EPSCs depending on
whether normal or reduced levels of PSD-95 were pres-
ent. These results suggest that endogenous PSD-95 has
a dominant effect over SAP97b such that the functional
role of SAP97b may best be revealed on a background
of greatly reduced PSD-95. Furthermore, they demon-
strate that the lack of effect of SAP97b when overex-
pressed in this and previous work (Ehrlich and Malinow,
2004; Schnell et al., 2002) is not due to some interference
in its function by the GFP tag (see Nakagawa et al., 2004).
Instead, whether or not synaptic effects of SAP97b are
observed may depend on the levels of PSD-95 present
at individual synapses and the magnitude of SAP97b
overexpression.
The N-Terminal Domains of SAP97 and PSD-95
Govern Their Effects on AMPAR EPSCs
Our results thus far demonstrate that SAP97b and PSD-
95a have different effects on AMPAR-mediated synaptic
transmission. To determine whether these differences
are due to their distinct N-terminal domains, we exam-
ined the effects of overexpressing the a-isoform of
SAP97, which contains a cysteine doublet similar to
that in PSD-95a rather than an L27 domain, and also the
effects of replacing endogenous PSD-95 with SAP97a.
Similar to PSD-95a, SAP97a dramatically increased
AMPAR EPSCs 2- to 3-fold when either overexpressed
or replacing endogenous PSD-95 (n = 26 and 18 pairs,
respectively) (Figure 3D). We next examined the effects
of replacing endogenous PSD-95 with PSD-95b, which
contains an L27 domain. Like SAP97b, this rescued the
AMPAR EPSCs only back to control cell levels (n = 23
pairs), in contrast to the 2- to 3-fold increase caused
by PSD-95a (Figure 3E). Similar to all previous experi-
ments, NMDAR EPSCs were not significantly affected
by either SAP97a or PSD-95b replacement constructs
(data not shown).
These results demonstrate that the N-terminal do-
mains of SAP97 and PSD-95 are responsible for their dif-
ferent effects on AMPAR EPSCs. Whereas the double
cysteine-containing a-isoforms have a much greater
effect on AMPAR-mediated synaptic transmission, the
L27 domain-containing b-isoforms are capable of rescu-
ing to control levels the reduced AMPAR EPSCs caused
by the silencing of endogenous PSD-95. These results
also suggest that additional sequence differences be-
tween PSD-95 and SAP97 not involving the N-terminal
Neuron
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(A) Amplitudes of AMPAR EPSCs expressing SAP97b versus control neurons.
(B) Amplitudes of AMPAR EPSCs expressing sh95 + SAP97b versus control neurons.
(C) Summary of effects on AMPAR EPSCs (left panel) and NMDAR EPSCs (right panel) of expressing sh95 alone, SAP97b alone, and both
together (n.s., p > 0.05; ***p < 0.001).
(D) Amplitudes of AMPAR EPSCs expressing sh95 + SAP97a versus control neurons (left panel) and summary of effects of replacing PSD-95 with
SAP97b versus SAP97a as well as overexpression of SAP97a (right panel) (***p < 0.001).
(E) Amplitudes of AMPAR EPSCs expressing sh95 + PSD-95b versus control neurons (left panel) and summary of effects of replacing PSD-95 with
PSD-95b versus PSD-95a (right panel) (***p < 0.001).
Gray symbols represent single pairs of recordings; black symbols show mean 6 SEM; p values were calculated with a paired Student’s t test
comparing absolute values of paired recordings.domains are unlikely to account for their functional dif-
ferences in this assay system.
Regulation of AMPAR EPSCs by L27 Domain
b-Isoforms Is Activity Dependent
Data from both overexpression of PSD-95a and acute
knockdown with sh95 suggest that PSD-95a plays an
important role in regulating AMPAR EPSCs (Figure 2).
However, the w40% reduction of AMPAR EPSCs by
acutely silencing endogenous PSD-95 was relatively
small, given that in cortical cultures, PSD-95 protein
level was decreased by >90% (Figure 1E). In addition,
in PSD-95 knockout mice, AMPAR-mediated synaptic
transmission is unaltered, despite a lack of upregulation
of other DLG-MAGUK protein levels (Migaud et al., 1998;
Yao et al., 2004) (Figure 1C). These data suggest that
there may be other factors that can regulate AMPAR-
mediated synaptic responses in the absence of PSD-
95, one obvious candidate being neural activity, which
dramatically influences the trafficking of AMPARs, often
via activation of NMDARs (Bredt and Nicoll, 2003; Mali-
now and Malenka, 2002; Song and Huganir, 2002). To
examine the effects of activity on the reduction in
AMPAR EPSCs caused by sh95, we applied the NMDAR
antagonist D-APV (25 mM) to reduce activity or the
GABAA receptor antagonist bicuculline (20 mM) to in-
crease excitatory activity to our culture media beginning
the day after virus infection. Treating slice cultures with
D-APV significantly enhanced the decrease in AMPAR
EPSCs caused by decreasing PSD-95 levels with sh95(n = 34 pairs) compared with interleaved control slice
cultures in which sh95 was expressed (n = 64 pairs)
(Figure 4A). In contrast, the addition of bicuculline to
the culture media rescued AMPAR EPSCs in sh95 ex-
pressing cells to control cell levels (n = 59 pairs)
(Figure 4A), demonstrating that synaptic activity by itself
is capable of rescuing synaptic strength when PSD-95
levels are greatly reduced. These results also suggest
that the w40% reduction in AMPAR EPSCs caused by
the sh95 under control condition is not larger because
of some activity-dependent compensation.
Because we only observed an effect of recombinant
SAP97b on AMPAR EPSCs when PSD-95 was greatly re-
duced, we speculated that the influence of activity on
the effectiveness of sh95 in reducing synaptic strength
might be mediated through the b-isoforms of endoge-
nous SAP97. To examine this hypothesis, we replaced
endogenous PSD-95 with SAP97b and cultured the
slices in the presence of D-APV. In contrast to control
conditions in which SAP97b rescues the decrease in
AMPAR EPSCs caused by sh95 (n = 35 pairs) (Figure 4B),
in the presence of D-APV this rescue was prevented
(n = 30 pairs) (Figure 4B). To test whether this influence
of activity is an intrinsic property of SAP97b or simply of
the N-terminal L27 domain, we repeated the experiment
with PSD-95b. Again the rescue of synaptic AMPAR
function that normally occurs when PSD-95b replaces
endogenous PSD-95 (n = 23 pairs) was blocked by
D-APV treatment (n = 18 pairs) (Figure 4C). It should be
noted that the reduction in synaptic strength caused
Regulation of Synapse Function by PSD-95 and SAP97
105Figure 4. Activity Regulates Effects of Both Acute Knockdown of PSD-95 and Its Replacement by b- but Not a-Isoforms of SAP97 and PSD-95
(A) Amplitudes of AMAPR EPSCs in cells expressing sh95 under various conditions versus control neurons (left panels) and summary of effects of
treatment with D-APV (25 mM) or bicuculline (20 mM).
(B) Amplitudes of AMAPR EPSCs in cells expressing sh95 + SAP97b in the presence of D-APV versus control neurons (left panel) and summary of
effects of replacement of PSD-95 with SAP97b under control conditions versus in the presence of D-APV. Effects of sh95 alone are also shown for
comparison.
(C) Amplitudes of AMPAR EPSCs in cells expressing sh95 + PSD-95b in the presence of D-APV versus control neurons (left panel) and summary
of effects of replacement of PSD-95 with PSD-95b under control conditions versus in the presence of D-APV.
(D and E) Same as (B) and (C), respectively, except slices were treated with bicuculline rather than D-APV.
(F) Same as (C), except PSD-95 was replaced with PSD-95a rather than PSD-95b. Right panel shows that neither D-APV nor bicuculline treat-
ments influenced the synaptic effects of PSD-95a.
(G) Same as (B), except PSD-95 was replaced with SAP97a and not SAP97b.
Gray symbols represent single pairs of recordings; black symbols show mean 6 SEM; p values were calculated with a paired Student’s t test
comparing absolute values of paired recordings.
For all panels, *p < 0.05; **p < 0.01; ***p < 0.001; n.s. p > 0.05.by sh95 alone in D-APV (Figure 4A) was greater than that
observed when SAP97b and PSD-95b were expressed
(Figures 4B and 4C; p < 0.02). This suggests SAP97b
and PSD-95b still could exert some effects on synaptic
function even in the presence of D-APV.As increased excitatory activity could rescue AMPAR-
mediated synaptic transmission in sh95-expressing
cells (Figure 4A), we next tested whether the rescue me-
diated by L27 domain-containing b-isoforms of SAP97
and PSD-95 (Figure 3) could similarly be enhanced by
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ence of bicuculline, replacement of endogenous PSD-
95 with either SAP97b (n = 29 pairs) or PSD-95b (n = 17
pairs) caused a significantly larger enhancement of
AMPAR EPSCs than that observed in control conditions
(Figures 4D and 4E). These results demonstrate that
activity and the b-isoforms of SAP97 and PSD-95 act
additively on AMPAR-mediated synaptic function and
suggest that increased activity enhances the effect of
these b-isoforms on AMPAR EPSCs.
To further test whether the N-terminal L27 domain in
these b-isoforms of DLG-MAGUKs was critical for the
activity dependence of their function, we examined
whether reducing activity influenced the synaptic ef-
fects of the a-isoforms of PSD-95 and SAP97. In con-
trast to the clear effects that D-APV treatment had on
the rescue of AMPAR EPSCs by the b-isoforms (Figures
4B and 4C), identical D-APV treatments had no effect
on the large enhancement of AMPAR EPSCs caused
by replacement of endogenous PSD-95 with PSD-95a
(n = 26 pairs) or SAP97a (n = 19 pairs) (Figures 4F and
4G). Similarly, bicuculline treatment also did not affect
the increase of AMPAR EPSCs caused by replacement
of endogenous PSD-95 with PSD-95a (Figure 4F, n =
16 pairs). These results provide further evidence that
the activity dependence of the synaptic function of
DLG-MAGUKs is due to the N-terminal L27 domains
that are only present in the b-isoforms.
Regulation of Synaptic Strength by b-Isoforms
of SAP97 and PSD-95 Is CaMKII Dependent
We have shown that SAP97b can rescue AMPAR-medi-
ated synaptic transmission to control levels when en-
dogenous PSD-95 is greatly reduced (Figure 3B) and
that this effect of SAP97b is significantly enhanced by ac-
tivity (Figure 4D). However, overexpression of SAP97b
in the presence of normal levels of PSD-95 had no effect
(Figure 3A), suggesting that PSD-95a normally has a
dominant effect in the regulation of AMPAR EPSCs. To
test whether increasing excitatory activity could override
the dominant effect of PSD-95a and allow SAP97b to
exert some synaptic effects, we treated slices with bicu-
culline during the expression of SAP97b. However, under
this condition SAP97b still had no detectable effect on
AMPAR EPSCs (n = 16 pairs) (Figure 5A). Thus, the dom-
inant effect of PSD-95a on synaptic function was inde-
pendent of the level of activity.
How does activity regulate the synaptic effects of the
b-isoforms of SAP97 and PSD-95? Because blockade
of NMDARs with D-APV had clear effects, we focused
on the possible role of one of the major targets of
NMDAR-mediated Ca2+ influx, calcium/calmodulin-
dependent protein kinase II (CaMKII) (Lisman et al.,
2002). This is a particularly intriguing candidate because
CaMKII phosphorylates SAP97 in vitro (Gardoni et al.,
2003; Mauceri et al., 2004), a modification that may influ-
ence its synaptic targeting (Mauceri et al., 2004). To test
for the involvement of CaMKII, we asked whether treat-
ment of slices with the inhibitor KN-93 (20 mM) affected
the rescue of AMPAR EPSCs by SAP97b when sh95
is expressed. This treatment had the same effect as D-
APV (n = 30 pairs) in that it prevented the return of
AMPAR EPSCs to control levels (n = 18 pairs, Figure 5B).
Similarly, KN-93 prevented the rescue of AMPAR EPSCsFigure 5. CaMKII Is Involved in the Regulation of AMPAR EPSCs by
SAP97b and PSD-95b
(A) (Left panel) Amplitudes of AMPAR EPSCs in cells express-
ing SAP97b versus control neurons from slices treated with bicucul-
line. (Right panel) Summary of effects of bicuculline treatment on
cells expressing SAP97b alone or sh95 + SAP97b (n.s. p > 0.05;
*p < 0.05, **p < 0.01; ***p < 0.001).
(B) (Left panel) Amplitudes of AMPAR EPSCs in cells expressing
sh95 + SAP97b versus control neurons from slices treated with
KN-93. (Right panel) Summary of effects of treatment of slices with
D-APV or KN-93 on cells expressing sh95 + SAP97b.
(C) Same as (B), except that PSD-95b was examined.
(D) (Left panel) Amplitudes of AMPAR EPSCs in cells expressing
sh95 + SAP97b versus control neurons from slices treated with bicu-
culline and KN-93. (Right panel) Summary of effects of treatment of
slices with bicuculline alone or bicuculline and KN-93 on cells ex-
pressing sh95 + SAP97b.
Gray symbols represent single pairs of recordings; black symbols
show mean6 SEM; p values were calculated with a paired Student’s
t test comparing absolute values of paired recordings.
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sh95 (n = 18 pairs, Figure 5C). To further examine the im-
portance of CaMKII, we expressed SAP97b and sh95
in slices treated with both KN-93 and bicuculline to
see if inhibition of CaMKII could prevent or decrease
the large activity-dependent enhancement of the ef-
fects of SAP97b on AMPAR EPSCs. Again, inhibition of
CaMKII (n = 19 pairs) greatly reduced the synaptic con-
sequences of expressing SAP97b (Figure 5D). These re-
sults suggest that CaMKII is one of the downstream
signaling molecules by which activity influences the reg-
ulation of synaptic strength by SAP97b.
Discussion
Restructuring the molecular architecture of excitatory
synapses is thought to be critically important for many
forms of activity- and experience-dependent plasticity.
In this context, critical components of the postsynaptic
density are members of the PDZ domain-containing,
DLG-MAGUK family of scaffolding proteins (Beique
and Andrade, 2003; Ehrlich and Malinow, 2004; El-Hus-
seini et al., 2002; Funke et al., 2005; Kim and Sheng,
2004; Montgomery et al., 2004; Scannevin and Huganir,
2000; Schnell et al., 2002; Stein et al., 2003). Using a mo-
lecular replacement strategy, we demonstrate that the
a- and b-isoforms of the two most well-characterized
DLG-MAGUKs, PSD-95 and SAP97, regulate basal
AMPAR-mediated synaptic strength via different mech-
anisms. The cysteine doublet-containing, palmitoylated
a-isoforms of PSD-95 and SAP97 increased AMPAR
EPSCs independent of the level of both endogenous
PSD-95 and activity. In contrast, the function of the
L27-containing b-isoforms was activity dependent and
completely masked by PSD-95a, the principle endoge-
nous isoform of PSD-95. Furthermore, the influence of
activity on the functional effects of SAP97b required
CaMKII activity. Thus, differences in the functional syn-
aptic effects of PSD-95a and SAP97b, the major endog-
enous isoforms of these DLG-MAGUKs, can be attrib-
uted solely to their N-terminal domains. Our results
also demonstrate that a molecular replacement strategy
is an important complement to more standard method-
ologies as it can reveal functions of a protein that cannot
be observed with overexpression or knockout/knock-
down approaches.
Previous work on the synaptic consequences of ex-
pressing SAP97 in hippocampal slice cultures has
yielded conflicting results (Ehrlich and Malinow, 2004;
Nakagawa et al., 2004; Schnell et al., 2002). It was
previously suggested that the lack of effect of SAP97
may be due to the disruption of its 3D structure by fusion
to GFP (Nakagawa et al., 2004). Two of our results indi-
cate that this is unlikely to be the case: (1) the same re-
combinant SAP97b fused to GFP that had no effect on
basal synaptic strength when expressed alone had a
clear effect when endogenous PSD-95 was reduced by
shRNA, (2) PSD-95b with GFP fused at its C terminus
had the same effects as SAP97b with GFP fused to its
N terminus. Instead, we suggest that two other factors—
the magnitude of its overexpression and the ‘‘state’’ of
the synapses in which it is expressed—contribute to the
functional synaptic consequences of expressing SAP97b.
With regard to the former, it is likely that using a eukaryoticexpression vector with a CMV promoter (pGW1; (Naka-
gawa et al., 2004) will result in greater expression than
lentivirus-mediated gene transfer. Consistent with this
proposal, the magnitude of increase in synaptic strength
caused by overexpression of PSD-95 was much higher in
the previous work using pGW1 to express PSD-95 and
SAP97 (7- to 8-fold; Nakagawa et al., 2004) than in the
present work (2- to 3-fold) or previous work that used
eukaryotic expression vectors (3.5-fold; Schnell et al.,
2002) or Sindbis virus to express PSD-95 (2- to 3-fold;
Ehrlich and Malinow, 2004). With regard to the ‘‘state’’
of the synapse, our results demonstrate that the level
of endogenous PSD-95 is one factor that greatly influ-
ences the functional synaptic effects of SAP97b.
The previous study that reported effects of SAP97 ex-
pression on synaptic strength in slice cultures (Naka-
gawa et al., 2004) suggested that its L27 domain was
important because of its ability to multimerize with itself
or other proteins. However, PSD-95 also multimerizes
(Christopherson et al., 2003; Hsueh et al., 1997) and
the importance of PSD-95 multimerization for its synap-
tic functions has not been tested. Therefore, it remains
unclear whether SAP97 multimerization underlies any
special features of its functions that distinguish it from
PSD-95. Here we demonstrate that the N-terminal L27
domain has the important role of conferring activity de-
pendence and CaMKII dependence to the functional
synaptic effects of SAP97 as well as PSD-95. In contrast,
the synaptic effects of the major endogenous isoform of
PSD-95, PSD-95a, as well as SAP97a, were unaffected
by activity manipulations. Thus differences in the PDZ,
SH3, and GK domains of PSD-95 and SAP97 as well as
differences in their intervening sequences are not in-
volved in conferring activity dependence. These results
also suggest that PSD-95 may not be a primary target of
the signaling pathways that mediate various forms of
activity-dependent synaptic delivery of AMPARs (Ehrlich
and Malinow, 2004; Stein et al., 2003). Consistent with
this conclusion, LTP is robustly expressed in PSD-95
knockout animals (Migaud et al., 1998).
Instead, our results implicate SAP97b as a possible
key target of the NMDAR/CaMKII signaling pathway
that is required for many forms of experience- and activ-
ity-dependent synaptic plasticity (Lisman et al., 2002).
Indeed, SAP97 can be phosphorylated by CaMKII at
S39, and this has been reported to enhance its targeting
to dendritic spines in dissociated cultured neurons
(Mauceri et al., 2004). However, several observations
make it unlikely that such a mechanism accounts for
the activity dependence and CaMKII dependence of
the effects of SAP97b on synaptic strength. First, an
S39D mutation in SAP97b, which enhanced spine local-
ization of SAP97 (Mauceri et al., 2004), did not result in
an increase in AMPAR EPSCs when overexpressed in
hippocampal slice cultures (data not shown). Second,
a search of the GenBank database revealed that only
the rat isoform of SAP97b contains a serine residue at
position 39; mouse and human isoforms do not, making
it less likely that phosphorylation of S39 of this isoform
of SAP97b (containing the I3 insert) is functionally impor-
tant. Third, the synaptic effects of PSD-95b, which does
not contain serine 39, were blocked by inhibition of
NMDARs and CaMKII in a manner identical to SAP97b.
Fourth, whereas the a-isoforms of SAP97 and PSD-95
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were localized preferentially in spine-like structures in
our slices, the b-isoforms displayed a diffuse somato-
dendritic staining pattern (J. Tsui and R.M., unpublished
data), results that are consistent with experiments ex-
amining endogenous SAP97b and PSD-95a (Cho et al.,
1992; Kim et al., 1996; Sans et al., 2001). This was an
intrinsic property of the b-isoforms themselves as the
placement of the GFP tag (N-terminal in SAP97b and
C-terminal in PSD-95b) made no difference in their sub-
cellular localization. Furthermore, the activity manipula-
tions that affected the magnitude of the effects of
SAP97b and PSD-95b on AMPAR EPSCs had no dis-
cernable effect on their synaptic localization (J. Tsui
and R.M., unpublished data). However, we cannot rule
out that undetectable activity-dependent changes in
the synaptic localization of SAP97b and PSD-95b and/
or their CaMKII-dependent phosphorylation on other
residues contributed to their functional effect on synap-
tic strength. Alternatively, CaMKII-dependent phos-
phorylation of other proteins, such as transmembrane
AMPA receptor regulatory proteins (TARPs) or AMPAR
subunits, might mediate the activity-dependent en-
hancement of AMPAR EPSCs via SAP97b or PSD-95b.
Our results also address the key issue of the func-
tional interplay between PSD-95 and SAP97 given that
their predominant endogenous isoforms are PSD-95a
and SAP97b. Although the synaptic effects of PSD-95a
were not influenced by activity, it had both a dominant
and restrictive role in controlling synaptic strength, pre-
sumably by influencing the incorporation of AMPARs
into the postsynaptic density (PSD) (Chen et al., 2000;
Ehrlich and Malinow, 2004; Schnell et al., 2002). It is
dominant in that in the present work and all studies per-
formed to date, the level of PSD-95a correlates with
AMPAR-mediated synaptic strength independent of other
variables such as activity or the preparation in which it
is studied (Beique and Andrade, 2003; Ehrlich and Mali-
now, 2004; El-Husseini et al., 2002; Funke et al., 2005;
Kim and Sheng, 2004; Montgomery et al., 2004; Scanne-
vin and Huganir, 2000; Schnell et al., 2002; Stein et al.,
2003). It is restrictive in that SAP97b could only affect
synaptic function in the absence of endogenous PSD-
95. How does PSD-95 subserve these functions? One
possibility is that PSD-95 serves as a ‘‘slot’’ protein (Ma-
linow et al., 2000) which, via interacting with AMPAR/
TARP complexes, controls the number of synaptic
AMPARs in the PSD (Schnell et al., 2002). Two lines of evi-
dence argue against PSD-95 being the sole slot protein.
First, in the absence of PSD-95, AMPAR EPSCs can be
normal. Second, during chronic activity manipulations
in dissociated neuronal cultures, synaptic PSD-95 levels
change in a direction diametrically opposite to that of
miniature excitatory postsynaptic current (mEPSC) am-
plitude (Ehlers, 2003; O’Brien et al., 1998; Turrigiano
et al., 1998). Therefore, other MAGUK family members
must also be able to fulfill this putative function.
SAP97b is unlikely to be one such MAGUK; in marked
contrast to PSD-95, its synaptic levels, as assayed by
light microscopy in our slice cultures, were not corre-
lated with synaptic strength. Therefore, a limitation of
this ‘‘slot’’ model is that it does not explain why de-
creasing the level of PSD-95a is required for SAP97b to
exert a functional synaptic effect. To account for theseobservations we propose that PSD-95a may also ‘‘gate’’
the synaptic incorporation of AMPARs and thereby limit
the access of extrasynaptic AMPARs to the PSD. In-
creasing its levels would provide more ‘‘gates’’ (and per-
haps more ‘‘slots;’’ the two roles are not mutually exclu-
sive), while in its absence, there would be free access of
extrasynaptic AMPARs to the PSD, the final level of syn-
aptic AMPARs still being dictated by the number of
‘‘slot’’ proteins.
In this model, SAP97b functions in an activity- and
CaMKII-dependent fashion to either facilitate the deliv-
ery of AMPARs to extrasynaptic membrane from intra-
cellular pools or trigger the release of AMPARs that are
retained at an extrasynaptic pool so they can be trans-
ported into synapses. In either scenario, translocation
of the SAP97b into the PSD, and perhaps into spines,
is not required. Consistent with the first proposal is the
observation that endogenous SAP97b associates with
AMPARs in an early step of the biosynthetic pathway
and is not bound to AMPARs localized on the plasma
membrane (Sans et al., 2001). Furthermore, SAP97b
overexpression in dissociated neuronal cultures leads
to an increase in surface synaptic AMPARs, suggesting
a role either in mobilizing the receptors from an intracel-
lular pool or diffusion of receptors from extrasynaptic to
synaptic sites (Rumbaugh et al., 2003).
We have assumed that the acute knockdown of PSD-
95 using RNAi and its simultaneous replacement with
recombinant forms of PSD-95 and SAP97 are less likely
to cause compensatory synaptic adaptations than tradi-
tional genetic knockout approaches. In this context
there are three major differences between RNAi and
knockout approaches. First, genetic deletion results in
loss of the protein throughout development and there-
fore may affect synaptic properties by influencing syn-
aptogenesis, whereas viral approaches allow the manip-
ulation of mature neurons. Second, the duration over
which the protein is absent and adaptations can occur
is longer when standard knockout approaches are
used. Using RNAi, the effects of PSD-95 knockdown
were clear after 3 days and stable for an additional 5
days. Third, knockout approaches involve deleting the
protein in all cells in a given brain area whereas the
lentivirus-mediated shRNA expression affects small
numbers of scattered cells, limiting the molecular ma-
nipulation to the postsynaptic cells under investigation.
However, this latter approach is not without its own lim-
itations. It still takes several days to take effect and the-
oretically may cause changes in network activity, which
in turn differentially influences synaptic function on the
molecularly modified cells. Thus, the results from exper-
iments using this molecular replacement strategy must
be considered in the context of the results obtained
from other approaches, each of which has its own dis-
tinct set of advantages and limitations.
In summary, we have presented evidence of addi-
tional important differences in the functional roles of
the predominant isoforms of PSD-95 and SAP97. Most
importantly, we have found that the N-terminal L27
domain in SAP97b confers activity dependence and
CaMKII dependence on both SAP97 and PSD-95. By
use of a molecular replacement approach, we have
also provided explanations for conflicting results in the
literature and the functional interplay between PSD-95
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presumably more stable component of the PSD (in that
its function is not affected by chronic activity), the func-
tional effects of SAP97 are highly dependent on activity.
Further work involving molecular replacement of SAP97
will be required to test its specific role in various forms
of synaptic plasticity.
Experimental Procedures
Dissociated Neuronal Cultures
Dissociated neuronal cultures were prepared from newborn
Sprague-Dawley pups as previously described with minor changes
(Stellwagen et al., 2005). Briefly, trypsinized hemispheres of cortex
were triturated and plated on poly-L-lysine coated 10 cm culture
dishes in B-27 supplemented Neurobasal media, and then refed
subsequently with N-2 supplemented MEM plus GlutaMax (Invitro-
gen). Glial growth was inhibited by FUDR at 3 DIV.
Antibodies and Western Blots
The following antibodies were used: mouse PSD-95 antibody (Affin-
ity Bioreagents), mouse a/b-DLG (SAP97) antibody (Stressgen),
mouse GFP antibody (JL-8, Clontech), rabbit synaptophysin anti-
body (Zymed), goat anti-mouse conjugated with Alexa 680 (Rock-
land), and goat anti-rabbit conjugated with Alexa 800 (Rockland).
Neuronal cultures were collected in ice-cold RIPA buffer (1% Triton
X-100, 0.1% SDS, 0.5% deoxycholic acid, 50 mM Na2HPO4, 150 mM
NaCl, 2 mM EDTA and protease inhibitor cocktail [Roche], [pH 7.4])
and diluted with SDS-PAGE sample buffer (BioRad). HEK293 cells
were transfected at 60%–80% confluency with expression con-
structs for PSD-95, SAP97, and PSD-93 (Parker et al., 2004). Cells
were harvested and lysed 24 hr after transfection in ice-cold RIPA
buffer and diluted with SDS-PAGE buffer. Hippocampi were col-
lected and homogenized in ice-cold homogenization buffer. A crude
synaptosomal fraction P2 was solubilized in SDS-PAGE sample
buffer after protein concentrations were adjusted (Schlu¨ter et al.,
1999). Samples were separated on 4%–12% gradient Bis-Tris gels
(Invitrogen), transferred onto nitrocellulose, and decorated with
the indicated antibodies (Schlu¨ter et al., 1999). Signals of fluorescent
dye-labeled secondary antibodies were detected and quantified
with an Odyssey Infrared Imaging System (Li-cor Biotechnology).
RT-PCR
Protocols were adapted from Lin et al. (Lin et al., 1997) with minor
modifications. Total RNA was isolated from different brain regions
of 21–23 day old rats using Trizol reagent (Invitrogen), and 5 mg of
each RNA sample was used in each 20 ml of randomly primed reverse
transcription (RT) reactions for first strand cDNA synthesis accord-
ing to the manufacturer’s protocol (SuperscriptII reverse transcrip-
tase; Invitrogen). Two microliters of cDNA from each RT reaction
was used for PCR amplification with annealing temperature of
58ºC. Two upstream primers, Pa (50-TTGTTGTCGTTGTTGAAATA
GGCAT) and Pb (50-ACTAAGCCAAACCGAAGACAGACAG) and one
downstream primer P2 (50-ACAAACCCGTGGACATTGTGAATGT)
were used in PCR amplification reactions to recognize either the
a- or b-isoform of SAP97 with the predicted PCR products of 238
bp and 393 bp, respectively. The pair of GAPDH primers in control
reactions was PGup (50- CAAGATGGTGAAGGTCGGTGTGAA) and
PGdn (50-CAGCACCAGCATCACCCCCATTT) that amplified a prod-
uct of 275 bp. Negative controls that lacked template confirmed
that reagents were not contaminated with cDNAs. The primers
flanked at least one intron so contamination by genomic DNA could
be ruled out.
Hippocampal Slice Cultures
Procedures for preparation of hippocampal slice cultures were
essentially as described (Stoppini et al., 1991), with minor modifica-
tions. Briefly, hippocampi of 8 day old rats were isolated, and 220–
300 mm slices were prepared using a Vibratome (Leica Microsys-
tems) in ice-cold sucrose substituted artificial cerebrospinal fluid
(ACSF; see Electrophysiology section). Slices were transferred
onto MilliCell Culture Plate Inserts (MilliPore) and cultured in Neuro-
basal-A medium supplemented with 1 mg/ml insulin, 0.5 mM ascorbicacid, and 20% horse serum. Media was changed every second day.
When slices were treated pharmacologically, 25 mM D-APV (Tocris),
20 mM bicuculline (Tocris), and/or 20 mM KN-93 (Calbiochem) were
included in the media 1 day after virus injection.
Virus Preparation and Infection
All lentiviral transfer vector constructs were modified from the orig-
inal FUGW vector backbone (Lois et al., 2002). For shRNA expres-
sion, an H1 promoter cassette from pSuper vector, including a hair-
pin (sh95) targeting the PSD-95 sequence GGA CAT CCA GGC ACA
CAA G, was cloned between the HIV-flap and ubiquitin promoter
(Figure 1D) (Brummelkamp et al., 2002). When the effect of shRNAs
was tested, the ubiquitin promoter-driven eGFP expression was
used to identify infected cells. For molecular replacement studies,
eGFP was replaced by fusion proteins of either C-terminally, eGFP-
tagged PSD-95a, PSD-95b, and SAP97a, or N-terminally, eGFP-
tagged SAP97b. Silent mutations were introduced in the PSD-95
construct target region of sh95 (GGAtATtCAaGCgCAtAAG), so that
the shRNA did not knock down the replacement constructs that
were expressed under regulation of the ubiquitin promoter. For the
production of lentiviral vectors, the transfer vector, the HIV-1 pack-
aging vector D8.9, and the VSVG envelope glycoprotein vector
were cotransfected into HEK293 fibroblasts using FUGENE6 trans-
fection reagent (Roche, Basel, Switzerland). Supernatants of culture
media were collected 48 hr after transfection and centrifuged at
50,000 3 g to concentrate the viral vector. To infect hippocampal
slice cultures, concentrated viral solutions were injected into the
CA1 pyramidal cell layer using a Picospritzer II (General Valve). To
infect cortical cultures, 500 ml of unconcentrated viral supernatant
was used for each 100 mm dish.
Electrophysiology
A single slice was removed from the insert and put in the recording
chamber where it was constantly perfused with ACSF containing
(in mM) 119 NaCl, 26 NaHCO3, 10 glucose, 2.5 KCl, 1 NaH2PO4,
4 MgSO4, and 4 CaCl2, constantly bubbled with 95% O2 and 5%
CO2. Picrotoxin (50 mM) was included to isolate EPSCs and chloroa-
denosine (1–2 mM) was added to reduce polysynaptic activity. All
experiments, except for those illustrated in Figures 2A–2C, were per-
formed 4–8 days after infection. A single, double-barreled glass
pipette filled with ACSF was used as a bipolar stimulation electrode
and was placed within 300 mm of the recording pipettes in stratum
radiatum. The pipette solution for whole-cell voltage-clamp record-
ings contained (in mM) 117.5 CsMeSO3, 10 HEPES, 10 TEACl, 8
NaCl, 15.5 CsCl, 1 MgCl2, 0.25 EGTA, 4 MgATP, 0.3 NaGTP, and 5
QX-314. Data were collected using an Axopatch 700A amplifier or
two Axopatch 1D amplifiers (Axon Instruments), digitized at 5 kHz
with the A/D converter PCI-MI0-16E-4 (National Instruments). Data
were acquired and analyzed on-line using custom routines written
with Igor Pro software (Wavemetrics). AMPAR EPSCs were re-
corded at 260 mV and measured using a 2 ms window around
the peak. NMDAR EPSCs are recorded at +40 mV and measured
60–65 ms after the initiation of the EPSC, a time point at which
AMPAR-mediated currents are absent or minimal. Small, hyperpolar-
izing voltage steps were given before each afferent stimulus allow-
ing on-line monitoring of input and series resistances. Stimulation
pulses were provided at 0.2 Hz. Simultaneous, dual whole-cell re-
cordings were established from an infected and closely adjacent un-
infected cell (as indicated by GFP expression and lack thereof).
AMPAR EPSCs were collected after adjusting stimulation strength
so that AMPAR EPSCs in control cells were 10–50 pA and 40 to 70
traces were averaged to obtain the basal AMPAR EPSCs from the
two cells. Cells were then depolarized to +40 mV and another 25
to 50 dual component EPSCs were collected to obtain a measure-
ment of NMDAR EPSCs. Comparisons between infected and unin-
fected cell responses were done using a paired t test. Statistical
analyses among different constructs and conditions were done
using one-way analysis of variation (ANOVA) and Tukey’s HSD t test.
Acknowledgments
We thank S. Lee, D. Jhung, and S. Wu for excellent technical assis-
tance, C. Garner and J. Tsui for helpful discussions, and C. Garner,
S. Grant, W.J. Nelson, G. Feng, and C. Lois for reagents and use of
Neuron
110equipment. This work was supported by NIH grants MH063394 (to
R.C.M.) and MH075220 (to W.X.) and a DFG Fellowship Schl592-1
(to O.M.S.).
Received: February 2, 2006
Revised: April 17, 2006
Accepted: May 17, 2006
Published: July 5, 2006
References
Beique, J.C., and Andrade, R. (2003). PSD-95 regulates synaptic
transmission and plasticity in rat cerebral cortex. J. Physiol. 546,
859–867.
Bredt, D.S., and Nicoll, R.A. (2003). AMPA receptor trafficking at ex-
citatory synapses. Neuron 40, 361–379.
Brummelkamp, T.R., Bernards, R., and Agami, R. (2002). A system
for stable expression of short interfering RNAs in mammalian cells.
Science 296, 550–553.
Cai, C., Coleman, S.K., Niemi, K., and Keinanen, K. (2002). Selective
binding of synapse-associated protein 97 to GluR-A alpha-amino-5-
hydroxy-3-methyl-4-isoxazole propionate receptor subunit is deter-
mined by a novel sequence motif. J. Biol. Chem. 277, 31484–31490.
Caruana, G., and Bernstein, A. (2001). Craniofacial dysmorphogene-
sis including cleft palate in mice with an insertional mutation in the
discs large gene. Mol. Cell. Biol. 21, 1475–1483.
Chen, L., Chetkovich, D.M., Petralia, R.S., Sweeney, N.T., Kawasaki,
Y., Wenthold, R.J., Bredt, D.S., and Nicoll, R.A. (2000). Stargazing
regulates synaptic targeting of AMPA receptors by two distinct
mechanisms. Nature 408, 936–943.
Chetkovich, D.M., Bunn, R.C., Kuo, S.H., Kawasaki, Y., Kohwi, M.,
and Bredt, D.S. (2002). Postsynaptic targeting of alternative post-
synaptic density-95 isoforms by distinct mechanisms. J. Neurosci.
22, 6415–6425.
Cho, K.O., Hunt, C.A., and Kennedy, M.B. (1992). The rat brain post-
synaptic density fraction contains a homolog of the Drosophila
discs-large tumor suppressor protein. Neuron 9, 929–942.
Christopherson, K.S., Sweeney, N.T., Craven, S.E., Kang, R., El-Hus-
seini Ael, D., and Bredt, D.S. (2003). Lipid- and protein-mediated
multimerization of PSD-95: implications for receptor clustering and
assembly of synaptic protein networks. J. Cell Sci. 116, 3213–3219.
Craven, S.E., El-Husseini, A.E., and Bredt, D.S. (1999). Synaptic tar-
geting of the postsynaptic density protein PSD-95 mediated by lipid
and protein motifs. Neuron 22, 497–509.
Ehlers, M.D. (2003). Activity level controls postsynaptic composition
and signaling via the ubiquitin-proteasome system. Nat. Neurosci. 6,
231–242.
Ehrlich, I., and Malinow, R. (2004). Postsynaptic density 95 controls
AMPA receptor incorporation during long-term potentiation and
experience-driven synaptic plasticity. J. Neurosci. 24, 916–927.
El-Husseini, A.D., Schnell, E., Dakoji, S., Sweeney, N., Zhou, Q.,
Prange, O., Gauthier-Campbell, C., Aguilera-Moreno, A., Nicoll,
R.A., and Bredt, D.S. (2002). Synaptic strength regulated by palmi-
tate cycling on PSD-95. Cell 108, 849–863.
El-Husseini, A.E., Schnell, E., Chetkovich, D.M., Nicoll, R.A., and
Bredt, D.S. (2000). PSD-95 involvement in maturation of excitatory
synapses. Science 290, 1364–1368.
Fukata, Y., Tzingounis, A.V., Trinidad, J.C., Fukata, M., Burlingame,
A.L., Nicoll, R.A., and Bredt, D.S. (2005). Molecular constituents of
neuronal AMPA receptors. J. Cell Biol. 169, 399–404.
Funke, L., Dakoji, S., and Bredt, D.S. (2005). Membrane-associated
guanylate kinases regulate adhesion and plasticity at cell junctions.
Annu. Rev. Biochem. 74, 219–245.
Gardoni, F., Mauceri, D., Fiorentini, C., Bellone, C., Missale, C., Cat-
tabeni, F., and Di Luca, M. (2003). CaMKII-dependent phosphoryla-
tion regulates SAP97/NR2A interaction. J. Biol. Chem. 278, 44745–
44752.
Hsueh, Y.P., Kim, E., and Sheng, M. (1997). Disulfide-linked head-to-
head multimerization in the mechanism of ion channel clustering by
PSD-95. Neuron 18, 803–814.Kim, E., and Sheng, M. (2004). PDZ domain proteins of synapses.
Nat. Rev. Neurosci. 5, 771–781.
Kim, E., Cho, K.O., Rothschild, A., and Sheng, M. (1996). Heteromul-
timerization and NMDA receptor-clustering activity of Chapsyn-110,
a member of the PSD-95 family of proteins. Neuron 17, 103–113.
Klocker, N., Bunn, R.C., Schnell, E., Caruana, G., Bernstein, A., Nic-
oll, R.A., and Bredt, D.S. (2002). Synaptic glutamate receptor cluster-
ing in mice lacking the SH3 and GK domains of SAP97. Eur. J. Neuro-
sci. 16, 1517–1522.
Lahey, T., Gorczyca, M., Jia, X.X., and Budnik, V. (1994). The Dro-
sophila tumor suppressor gene dlg is required for normal synaptic
bouton structure. Neuron 13, 823–835.
Lee, S., Fan, S., Makarova, O., Straight, S., and Margolis, B. (2002). A
novel and conserved protein-protein interaction domain of mamma-
lian Lin-2/CASK binds and recruits SAP97 to the lateral surface of
epithelia. Mol. Cell. Biol. 22, 1778–1791.
Leonard, A.S., Davare, M.A., Horne, M.C., Garner, C.C., and Hell,
J.W. (1998). SAP97 is associated with the alpha-amino-3-hydroxy-
5-methylisoxazole-4-propionic acid receptor GluR1 subunit. J.
Biol. Chem. 273, 19518–19524.
Lin, Z., Haus, S., Edgerton, J., and Lipscombe, D. (1997). Identifica-
tion of functionally distinct isoforms of the N-type Ca2+ channel in
rat sympathetic ganglia and brain. Neuron 18, 153–166.
Lisman, J., Schulman, H., and Cline, H. (2002). The molecular basis
of CaMKII function in synaptic and behavioural memory. Nat. Rev.
Neurosci. 3, 175–190.
Lois, C., Hong, E.J., Pease, S., Brown, E.J., and Baltimore, D. (2002).
Germline transmission and tissue-specific expression of transgenes
delivered by lentiviral vectors. Science 295, 868–872.
Malinow, R., and Malenka, R.C. (2002). AMPA receptor trafficking
and synaptic plasticity. Annu. Rev. Neurosci. 25, 103–126.
Malinow, R., Mainen, Z.F., and Hayashi, Y. (2000). LTP mechanisms:
from silence to four-lane traffic. Curr. Opin. Neurobiol. 10, 352–357.
Mauceri, D., Cattabeni, F., Di Luca, M., and Gardoni, F. (2004). Cal-
cium/calmodulin-dependent protein kinase II phosphorylation
drives synapse-associated protein 97 into spines. J. Biol. Chem.
279, 23813–23821.
McGee, A.W., Topinka, J.R., Hashimoto, K., Petralia, R.S., Kakizawa,
S., Kauer, F.W., Aguilera-Moreno, A., Wenthold, R.J., Kano, M., and
Bredt, D.S. (2001). PSD-93 knock-out mice reveal that neuronal
MAGUKs are not required for development or function of parallel
fiber synapses in cerebellum. J. Neurosci. 21, 3085–3091.
McLaughlin, M., Hale, R., Ellston, D., Gaudet, S., Lue, R.A., and Viel,
A. (2002). The distribution and function of alternatively spliced inser-
tions in hDlg. J. Biol. Chem. 277, 6406–6412.
Migaud, M., Charlesworth, P., Dempster, M., Webster, L.C., Watabe,
A.M., Makhinson, M., He, Y., Ramsay, M.F., Morris, R.G., Morrison,
J.H., et al. (1998). Enhanced long-term potentiation and impaired
learning in mice with mutant postsynaptic density-95 protein. Nature
396, 433–439.
Montgomery, J.M., Zamorano, P.L., and Garner, C.C. (2004).
MAGUKs in synapse assembly and function: an emerging view.
Cell. Mol. Life Sci. 61, 911–929.
Muller, B.M., Kistner, U., Veh, R.W., Cases-Langhoff, C., Becker, B.,
Gundelfinger, E.D., and Garner, C.C. (1995). Molecular characteriza-
tion and spatial distribution of SAP97, a novel presynaptic protein
homologous to SAP90 and the Drosophila discs-large tumor sup-
pressor protein. J. Neurosci. 15, 2354–2366.
Nakagawa, T., Futai, K., Lashuel, H.A., Lo, I., Okamoto, K., Walz, T.,
Hayashi, Y., and Sheng, M. (2004). Quaternary structure, protein dy-
namics, and synaptic function of SAP97 controlled by L27 domain
interactions. Neuron 44, 453–467.
O’Brien, R.J., Kamboj, S., Ehlers, M.D., Rosen, K.R., Fischbach,
G.D., and Huganir, R.L. (1998). Activity-dependent modulation of
synaptic AMPA receptor accumulation. Neuron 21, 1067–1078.
Parker, M.J., Zhao, S., Bredt, D.S., Sanes, J.R., and Feng, G. (2004).
PSD93 regulates synaptic stability at neuronal cholinergic synapses.
J. Neurosci. 24, 378–388.
Rumbaugh, G., Sia, G.M., Garner, C.C., and Huganir, R.L. (2003).
Synapse-associated protein-97 isoform-specific regulation of
Regulation of Synapse Function by PSD-95 and SAP97
111surface AMPA receptors and synaptic function in cultured neurons.
J. Neurosci. 23, 4567–4576.
Sans, N., Petralia, R.S., Wang, Y.X., Blahos, J., 2nd, Hell, J.W., and
Wenthold, R.J. (2000). A developmental change in NMDA receptor-
associated proteins at hippocampal synapses. J. Neurosci. 20,
1260–1271.
Sans, N., Racca, C., Petralia, R.S., Wang, Y.X., McCallum, J., and
Wenthold, R.J. (2001). Synapse-associated protein 97 selectively
associates with a subset of AMPA receptors early in their biosyn-
thetic pathway. J. Neurosci. 21, 7506–7516.
Scannevin, R.H., and Huganir, R.L. (2000). Postsynaptic organiza-
tion and regulation of excitatory synapses. Nat. Rev. Neurosci. 1,
133–141.
Schlu¨ter, O.M., Schnell, E., Verhage, M., Tzonopoulos, T., Nicoll,
R.A., Janz, R., Malenka, R.C., Geppert, M., and Su¨dhof, T.C.
(1999). Rabphilin knock-out mice reveal that rabphilin is not required
for rab3 function in regulating neurotransmitter release. J. Neurosci.
19, 5834–5846.
Schnell, E., Sizemore, M., Karimzadegan, S., Chen, L., Bredt, D.S.,
and Nicoll, R.A. (2002). Direct interactions between PSD-95 and star-
gazin control synaptic AMPA receptor number. Proc. Natl. Acad. Sci.
USA 99, 13902–13907.
Song, I., and Huganir, R.L. (2002). Regulation of AMPA receptors
during synaptic plasticity. Trends Neurosci. 25, 578–588.
Stein, V., House, D.R., Bredt, D.S., and Nicoll, R.A. (2003). Postsyn-
aptic density-95 mimics and occludes hippocampal long-term po-
tentiation and enhances long-term depression. J. Neurosci. 23,
5503–5506.
Stellwagen, D., Beattie, E.C., Seo, J.Y., and Malenka, R.C. (2005).
Differential regulation of AMPA receptor and GABA receptor traffick-
ing by tumor necrosis factor-alpha. J. Neurosci. 25, 3219–3228.
Stoppini, L., Buchs, P.A., and Muller, D. (1991). A simple method for
organotypic cultures of nervous tissue. J. Neurosci. Methods 37,
173–182.
Topinka, J.R., and Bredt, D.S. (1998). N-terminal palmitoylation of
PSD-95 regulates association with cell membranes and interaction
with K+ channel Kv1.4. Neuron 20, 125–134.
Turrigiano, G.G., Leslie, K.R., Desai, N.S., Rutherford, L.C., and Nel-
son, S.B. (1998). Activity-dependent scaling of quantal amplitude in
neocortical neurons. Nature 391, 892–896.
Woods, D.F., and Bryant, P.J. (1991). The discs-large tumor sup-
pressor gene of Drosophila encodes a guanylate kinase homolog lo-
calized at septate junctions. Cell 66, 451–464.
Wu, H., Reissner, C., Kuhlendahl, S., Coblentz, B., Reuver, S., Kin-
dler, S., Gundelfinger, E.D., and Garner, C.C. (2000). Intramolecular
interactions regulate SAP97 binding to GKAP. EMBO J. 19, 5740–
5751.
Yao, W.D., Gainetdinov, R.R., Arbuckle, M.I., Sotnikova, T.D., Cyr,
M., Beaulieu, J.M., Torres, G.E., Grant, S.G., and Caron, M.G.
(2004). Identification of PSD-95 as a regulator of dopamine-medi-
ated synaptic and behavioral plasticity. Neuron 41, 625–638.
